Assessment of antibody responses against gp41 in HIV-1-infected patients using soluble gp41 fusion proteins and peptides derived from M group consensus envelope

Human immunodeficiency virus type 1 (HIV-1) transmembrane glycoprotein gp41 is targeted by broadly-reactive neutralizing antibodies 2F5 and 4E10, making it an attractive target for vaccine development. To better assess immunogenic properties of gp41, we generated five soluble glutathione S-transfera...

Descripción completa

Detalles Bibliográficos
Autores principales: Penn-Nicholson, Adam, Han, Dong P., Kim, Soon J., Park, Hanna, Ansari, Rais, Montefiori, David C., Cho, Michael W.
Formato: Texto
Lenguaje:English
Publicado: Elsevier Inc. 2008
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2293309/
https://www.ncbi.nlm.nih.gov/pubmed/18068750
http://dx.doi.org/10.1016/j.virol.2007.11.009

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2293309/
https://www.ncbi.nlm.nih.gov/pubmed/18068750
http://dx.doi.org/10.1016/j.virol.2007.11.009

Ejemplares similares